Molecular Breast Imaging-guided Percutaneous Biopsy of Breast Lesions: A New Frontier on Breast Intervention

Overview

Journal J Breast Imaging

Publisher Oxford University Press

Specialties Oncology
Radiology

Date 2020 Oct 5

PMID 33015619

Citations 5

Authors

Beatriz E Adrada

Tanya Moseley

S Cheenu Kappadath

Gary J Whitman

Gaiane M Rauch

Affiliations

Soon will be listed here.

Abstract

Molecular breast imaging (MBI) is an increasingly recognized nuclear medicine imaging modality to detect breast lesions suspicious for malignancy. Recent advances have allowed the development of tissue sampling of MBI-detected lesions using a single-headed camera (breast-specific gamma imaging system) or a dual-headed camera system (MBI system). In this article, we will review current indications of MBI, differences of the two single- and dual-headed camera systems, the appropriate selection of biopsy equipment, billing considerations, and radiation safety. It will also include practical considerations and guidance on how to integrate MBI and MBI-guided biopsy in the current breast imaging workflow.

Citing Articles

Recent Advances in Image-Guided Tissue Sampling.

Musaddaq T, Musaddaq B Cureus. 2024; 16(10):e71613.

PMID: 39553029 PMC: 11566127. DOI: 10.7759/cureus.71613.

The Utility of Second-Look US to Evaluate Abnormal Molecular Breast Imaging Findings: A Retrospective Study.

Teichgraeber D, Bassett R, Whitman G J Breast Imaging. 2024; 7(1):27-34.

PMID: 39441197 PMC: 11770226. DOI: 10.1093/jbi/wbae059.

Innovative Advances in Molecular Breast Imaging Biopsy.

Fowler A Radiol Imaging Cancer. 2024; 6(4):e240135.

PMID: 38940692 PMC: 11287228. DOI: 10.1148/rycan.240135.

Molecular Breast Imaging Biopsy with a Dual-Detector System.

Hunt K, Conners A, Gray L, Hruska C, OConnor M Radiol Imaging Cancer. 2024; 6(4):e230186.

PMID: 38847615 PMC: 11287224. DOI: 10.1148/rycan.230186.

Updates in Molecular Breast Imaging.

Hruska C Semin Roentgenol. 2022; 57(2):134-138.

PMID: 35523526 PMC: 9077005. DOI: 10.1053/j.ro.2021.12.006.

References

Hruska C, Conners A, Jones K, OConnor M, Moriarty J, Boughey J . Diagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts. AJR Am J Roentgenol. 2015; 204(6):1345-53. PMC: 5036572. DOI: 10.2214/AJR.14.13306. View

Kim B . Usefulness of breast-specific gamma imaging as an adjunct modality in breast cancer patients with dense breast: a comparative study with MRI. Ann Nucl Med. 2011; 26(2):131-7. DOI: 10.1007/s12149-011-0544-5. View

Vlahiotis A, Griffin B, Stavros A, Margolis J . Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography. Clinicoecon Outcomes Res. 2018; 10:157-167. PMC: 5875586. DOI: 10.2147/CEOR.S150260. View

Raikhlin A, Curpen B, Warner E, Betel C, Wright B, Jong R . Breast MRI as an adjunct to mammography for breast cancer screening in high-risk patients: retrospective review. AJR Am J Roentgenol. 2015; 204(4):889-97. DOI: 10.2214/AJR.13.12264. View

Pullicino R, Radon M, Biswas S, Bhojak M, Das K . A Review of the Current Evidence on Gadolinium Deposition in the Brain. Clin Neuroradiol. 2018; 28(2):159-169. DOI: 10.1007/s00062-018-0678-0. View

Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist L . Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002; 359(9310):909-19. DOI: 10.1016/S0140-6736(02)08020-0. View

Taillefer R . The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin Nucl Med. 1999; 29(1):16-40. DOI: 10.1016/s0001-2998(99)80027-0. View

Collarino A, Olmos R, van Berkel L, Neijenhuis P, Wijers L, Smit F . The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery. Breast Cancer Res Treat. 2018; 169(3):513-522. PMC: 5953986. DOI: 10.1007/s10549-018-4706-1. View

Zhang A, Li P, Liu Q, Song S . Breast-specific gamma camera imaging with Tc-MIBI has better diagnostic performance than magnetic resonance imaging in breast cancer patients: A meta-analysis. Hell J Nucl Med. 2017; 20(1):26-35. DOI: 10.1967/s002449910503. View

10.

Guindalini R, Zheng Y, Abe H, Whitaker K, Yoshimatsu T, Walsh T . Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in Mutation Carriers. Clin Cancer Res. 2018; 25(6):1786-1794. PMC: 6395536. DOI: 10.1158/1078-0432.CCR-18-0200. View

11.

Kuhn K, Rapelyea J, Torrente J, Teal C, Brem R . Comparative Diagnostic Utility of Low-Dose Breast-Specific Gamma Imaging to Current Clinical Standard. Breast J. 2015; 22(2):180-8. DOI: 10.1111/tbj.12550. View

12.

Murphy K, Brunberg J . Adult claustrophobia, anxiety and sedation in MRI. Magn Reson Imaging. 1997; 15(1):51-4. DOI: 10.1016/s0730-725x(96)00351-7. View

13.

Collarino A, Olmos R, Neijenhuis P, den Hartog W, Smit F, de Geus-Oei L . First Clinical Experience Using Stereotactic Breast Biopsy Guided by Tc-Sestamibi. AJR Am J Roentgenol. 2017; 209(6):1367-1373. DOI: 10.2214/AJR.17.18083. View

14.

Huang W, Fisher P, Dulaimy K, Tudorica L, OHea B, Button T . Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology. 2004; 232(2):585-91. DOI: 10.1148/radiol.2322030547. View

15.

Hruska C . Molecular Breast Imaging for Screening in Dense Breasts: State of the Art and Future Directions. AJR Am J Roentgenol. 2016; 208(2):275-283. DOI: 10.2214/AJR.16.17131. View

16.

Rauch G, Adrada B . Comparison of Breast MR Imaging with Molecular Breast Imaging in Breast Cancer Screening, Diagnosis, Staging, and Treatment Response Evaluation. Magn Reson Imaging Clin N Am. 2018; 26(2):273-280. DOI: 10.1016/j.mric.2017.12.009. View

17.

Goldsmith S, Parsons W, Guiberteau M, Stern L, Lanzkowsky L, Weigert J . SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1.0. J Nucl Med Technol. 2010; 38(4):219-24. DOI: 10.2967/jnmt.110.082271. View

18.

Hruska C, Weinmann A, Tello Skjerseth C, Wagenaar E, Conners A, Tortorelli C . Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part II. Evaluation in patients. Med Phys. 2012; 39(6):3476-83. PMC: 3376157. DOI: 10.1118/1.4719959. View

19.

Maublant J, Zhang Z, Rapp M, Ollier M, Michelot J, Veyre A . In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med. 1993; 34(11):1949-52. View

20.

Tao A, Hruska C, Conners A, Hunt K, Swanson T, Tran T . Dose Reduction in Molecular Breast Imaging With a New Image-Processing Algorithm. AJR Am J Roentgenol. 2019; 214(1):185-193. DOI: 10.2214/AJR.19.21582. View